Mid-market scope SenoRx operates with 51-200 employees and has established a field sales force serving over 2,000 breast diagnostic and treatment centers in the US and Canada, indicating a mid-market sales approach with broad institutional access that can be leveraged for expanding product adoption.

Global distribution Products are sold through distribution partners in more than 30 countries outside the US and Canada, presenting opportunities to partner with distributors for enter new regional markets and accelerate international sales of biopsy and radiotherapy devices.

Integrated solutions Portfolio includes both diagnostic (vacuum-assisted biopsy systems) and therapeutic (MLB applicator for brachytherapy) devices, plus integration of ultrasound with biopsy, offering cross-sell and upsell potential across oncology care pathways.

Format of care Thousands of units deployed in breast centers, hospitals, outpatient centers, and radiation oncology centers suggest strong demand across multiple care settings, signaling opportunities to target multi-site accounts with bundled equipment and service contracts.

Financially lean With revenue in the lower end of tens of millions and a disclosed funding level, SenoRx presents a growth-ready profile where incentives for capacity expansion, service offerings, and regional channel partnerships can unlock accelerated revenue generation.